Filter
5870
Filtered Results: 5870
Text search:
National
Medicines
Policy
Featured
Recommendations
473
New Publications
1570
Language
Document type
No document type
3303
Studies & Reports
1104
Guidelines
706
Manuals
304
Strategic & Response Plan
219
Training Material
90
Fact sheets
73
Situation Updates
40
Resource Platforms
12
Brochures
7
Online Courses
6
Infographics
5
App
1
Countries / Regions
India
243
Global
214
Kenya
186
South Africa
139
Uganda
128
Ethiopia
128
Nepal
123
Western and Central Europe
115
Nigeria
111
Latin America and the Carribbean
100
Sierra Leone
99
Malawi
95
Liberia
95
Tanzania
87
Africa
83
Bangladesh
81
Myanmar / Burma
81
Zambia
78
Ghana
77
Ukraine
71
Rwanda
67
Eastern Europe
51
Syria
47
Namibia
46
Zimbabwe
45
South–East Asia Region
45
Philippines
42
Asia
36
Lesotho
35
Venezuela
34
Congo, Democratic Republic of
34
Paraguay
32
Mozambique
31
Russia
30
Colombia
28
Cambodia
28
Indonesia
28
Senegal
26
Guinea
26
Brazil
26
Burkina Faso
23
Botswana
23
South Sudan
23
Peru
22
Haiti
22
West and Central Africa
22
Cameroon
21
East and Southern Africa
21
Yemen
20
Germany
19
Middle East and North Africa
19
Eswatini/ Swaziland
19
Eastern Europe and Central Asia
16
Pakistan
16
Benin
15
Afghanistan
15
Bolivia
14
Sudan
14
Ecuador
14
Thailand
13
Moldova
13
Chile
11
USA
11
Vietnam
11
Lebanon
10
Sri Lanka
10
Somalia
10
Madagascar
10
Tajikistan
9
Jordan
9
Western Pacific Region
9
China
8
Albania
8
North America
8
North Macedonia
7
Mexico
7
Southern Africa
7
Georgia
7
Mali
7
El Salvador
6
Laos
6
Poland
6
Iraq
6
Turkey
5
Iran
5
Kyrgyzstan
5
United Kingdom
5
Argentina
5
Central African Republic
5
Libya
5
Kazakhstan
4
Canada
4
Burundi
4
Hungary
4
Saudi Arabia
4
Papua New Guinea
4
Egypt
4
Romania
4
Palestine
4
Timor Leste/ East Timor
3
Gambia
3
Fiji
3
Estonia
3
Morocco
3
Jamaica
3
Mauritius
3
Spain
3
Belarus
3
Côte d’Ivoire / Ivory Coast
3
Angola
3
Bhutan
3
Serbia
2
Niger
2
Qatar
2
Bulgaria
2
Armenia
2
Guinea-Bissau
2
Lithuania
2
Gabon
2
Turkmenistan
2
Japan
2
France
2
Tunisia
2
Portugal
2
Bosnia and Herzegovina
2
Greece
2
Honduras
2
Guatemala
2
Switzerland
1
Togo
1
Uzbekistan
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Israel
1
Latvia
1
Djibouti
1
Slovakia
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
2295
Clinical Guidelines
460
Public Health
365
Women & Child Health
284
Key Resources
186
Capacity Building
68
Pharmacy & Technologies
66
Annual Report MEDBOX
1
Toolboxes
HIV
509
Mental Health
475
COVID-19
410
TB
385
AMR
253
Planetary Health
190
Disability
182
Caregiver
170
Pharmacy
156
Rapid Response
137
Conflict
132
Ebola
123
NCDs
119
Global Health Education
108
NTDs
103
Refugee
91
Health Financing Toolbox
57
Natural Hazards
53
Specific Hazards
33
Zika
23
Polio
20
Social Ethics
18
Cholera
13
Health Financing
2
The purpose of these guidelines is to give practical advice to doctors so that all services and models of care used by doctors and health workers are encouraged to consider the use of telemedicine as a part of normal practice. These guidelines will assist the medical practitioner in pursuing a sound...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
COVID-19 has turned the world upside down. Everything has been impacted. How we live and interact with each other, how we work and communicate, how we move around and travel. Every aspect of our lives has been affected.
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information from trustworthy sources. Information is presented in...
The COVID-19 pandemic has affected everyone, including key populations at higher risk of HIV. And the gains made against other infectious diseases, including HIV, are at risk of being reversed as a result of disruptions caused by COVID-19. This is the background to a new report published by FHI 360,...
The report underscores that sexual and reproductive health and rights are often the first to be sacrificed during epidemics and that the gains of the past decade must be protected. The report also makes it clear that scarce resources must be focused on the most marginalized women and girls, includin...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i...
The main objective of this guidance is to provide scientific advice on public health principles and considerations for infection and prevention control of COVID-19 in migrant and refugee reception and detention centres in the European Union and European Economic Area (EU/EEA) and the United Kingdom ...
Updated 20 Nov. 2020
Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of h...
Start Free Stay Free AIDS Free - 2020 report
recommended
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support ...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
Previous pandemics have demonstrated that more people could die from the indirect consequences of an outbreak than from the disease itself. As the fight against the pandemic is pushing millions into poverty and hunger, COVID-19 will likely be no different.
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
These include taking proactive measures to ensure that people, particularly people in vulnerable groups, can access HIV treatment and prevention services, designating and supporting essential workers, including community-led organizations, and implementing measures to prevent and address gender-base...
